Correlation Between Viking Therapeutics and OnKure Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and OnKure Therapeutics,, you can compare the effects of market volatilities on Viking Therapeutics and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and OnKure Therapeutics,.

Diversification Opportunities for Viking Therapeutics and OnKure Therapeutics,

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Viking and OnKure is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and OnKure Therapeutics, go up and down completely randomly.

Pair Corralation between Viking Therapeutics and OnKure Therapeutics,

Given the investment horizon of 90 days Viking Therapeutics is expected to generate 1.42 times more return on investment than OnKure Therapeutics,. However, Viking Therapeutics is 1.42 times more volatile than OnKure Therapeutics,. It trades about 0.06 of its potential returns per unit of risk. OnKure Therapeutics, is currently generating about -0.03 per unit of risk. If you would invest  2,427  in Viking Therapeutics on September 1, 2024 and sell it today you would earn a total of  2,867  from holding Viking Therapeutics or generate 118.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viking Therapeutics  vs.  OnKure Therapeutics,

 Performance 
       Timeline  
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Viking Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
OnKure Therapeutics, 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in OnKure Therapeutics, are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, OnKure Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Viking Therapeutics and OnKure Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viking Therapeutics and OnKure Therapeutics,

The main advantage of trading using opposite Viking Therapeutics and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.
The idea behind Viking Therapeutics and OnKure Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios